Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kuhlmann

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten|October 1, 1978
[Mutual effects of drugs in the gastrointestinal tract]J Kuhlmann
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
Drug interaction studies during drug development: which, when, how?J Kuhlmann
Deutsche Medizinische Wochenschrift (1946)|January 13, 1984
[Digitoxin blood picture and renal elimination in long-term therapy with aluminum-magnesium hydroxide gel]J Kuhlmann
Medizinische Klinik (Praxis-Ausg.)|January 15, 1982
[Causes of digitalis poisoning]J Kuhlmann
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1984
Use of cholestyramine in three patients with beta-acetyldigoxin, beta-methyldigoxin and digitoxin intoxicationJ Kuhlmann
Deutsche Medizinische Wochenschrift (1946)|May 28, 1982
[No advantages of acetyldigoxin and methyldigoxin compared to digoxin]J Kuhlmann
Ernst Schering Research Foundation Workshop|November 23, 2006
The applications of biomarkers in early clinical drug development to improve decision-making processesJ Kuhlmann
Medizinische Klinik (Munich, Germany : 1983)|July 17, 1999
[Responsibilities of clinical pharmacology in the early phase of drug development]J Kuhlmann
Medizinische Klinik (Munich, Germany : 1983)|June 14, 2000
[Responsibilities of clinical pharmacology in the early phase of drug development]J Kuhlmann
Clinical Pharmacology and Therapeutics|February 1, 1985
Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxinJ Kuhlmann
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Medizinische Monatsschrift Fur Pharmazeuten|October 1, 1978
[Mutual effects of drugs in the gastrointestinal tract]J Kuhlmann
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
Drug interaction studies during drug development: which, when, how?J Kuhlmann
Deutsche Medizinische Wochenschrift (1946)|January 13, 1984
[Digitoxin blood picture and renal elimination in long-term therapy with aluminum-magnesium hydroxide gel]J Kuhlmann
Medizinische Klinik (Praxis-Ausg.)|January 15, 1982
[Causes of digitalis poisoning]J Kuhlmann
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1984
Use of cholestyramine in three patients with beta-acetyldigoxin, beta-methyldigoxin and digitoxin intoxicationJ Kuhlmann
Deutsche Medizinische Wochenschrift (1946)|May 28, 1982
[No advantages of acetyldigoxin and methyldigoxin compared to digoxin]J Kuhlmann
Ernst Schering Research Foundation Workshop|November 23, 2006
The applications of biomarkers in early clinical drug development to improve decision-making processesJ Kuhlmann
Medizinische Klinik (Munich, Germany : 1983)|July 17, 1999
[Responsibilities of clinical pharmacology in the early phase of drug development]J Kuhlmann
Medizinische Klinik (Munich, Germany : 1983)|June 14, 2000
[Responsibilities of clinical pharmacology in the early phase of drug development]J Kuhlmann
Clinical Pharmacology and Therapeutics|February 1, 1985
Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxinJ Kuhlmann
Pageof 16